Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation

S. E. Wright, Z. H A Shaikh, J. A. Castillo-Lugo, B. Tanriover

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Immune globulin intravenous (human) (IGIV) is effective in the treatment of various autoimmune and inflammatory disorders. Recently, high-dose IGIV 2 g/kg has been utilized in the treatment of antibody-mediated rejection in solid organ transplantation. We report a renal transplant recipient who developed aseptic meningitis and diplopia from abducens nerve (cranial nerve VI) palsy following IGIV administration for antibody-mediated rejection. Potential mechanisms of the IGIV-related aseptic meningitis are elaborated. Clinicians should be aware of aseptic meningitis and cranial nerve palsy as an adverse reaction to IGIV exposure and monitor for its signs and symptoms.

Original languageEnglish (US)
Pages (from-to)294-297
Number of pages4
JournalTransplant Infectious Disease
Volume10
Issue number4
DOIs
StatePublished - Aug 2008

Fingerprint

Abducens Nerve Diseases
Aseptic Meningitis
Intravenous Immunoglobulins
Kidney Transplantation
Abducens Nerve
Cranial Nerve Diseases
Diplopia
Antibodies
Organ Transplantation
Signs and Symptoms
Kidney
Therapeutics

Keywords

  • Abducens nerve palsy
  • Adverse effect
  • Aseptic meningitis
  • Diplopia
  • IGIV
  • Immune globulin intravenous
  • Renal transplant

ASJC Scopus subject areas

  • Transplantation
  • Microbiology (medical)
  • Immunology

Cite this

Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation. / Wright, S. E.; Shaikh, Z. H A; Castillo-Lugo, J. A.; Tanriover, B.

In: Transplant Infectious Disease, Vol. 10, No. 4, 08.2008, p. 294-297.

Research output: Contribution to journalArticle

@article{e573b34960774a98a7a6e0ba059f37ca,
title = "Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation",
abstract = "Immune globulin intravenous (human) (IGIV) is effective in the treatment of various autoimmune and inflammatory disorders. Recently, high-dose IGIV 2 g/kg has been utilized in the treatment of antibody-mediated rejection in solid organ transplantation. We report a renal transplant recipient who developed aseptic meningitis and diplopia from abducens nerve (cranial nerve VI) palsy following IGIV administration for antibody-mediated rejection. Potential mechanisms of the IGIV-related aseptic meningitis are elaborated. Clinicians should be aware of aseptic meningitis and cranial nerve palsy as an adverse reaction to IGIV exposure and monitor for its signs and symptoms.",
keywords = "Abducens nerve palsy, Adverse effect, Aseptic meningitis, Diplopia, IGIV, Immune globulin intravenous, Renal transplant",
author = "Wright, {S. E.} and Shaikh, {Z. H A} and Castillo-Lugo, {J. A.} and B. Tanriover",
year = "2008",
month = "8",
doi = "10.1111/j.1399-3062.2007.00294.x",
language = "English (US)",
volume = "10",
pages = "294--297",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation

AU - Wright, S. E.

AU - Shaikh, Z. H A

AU - Castillo-Lugo, J. A.

AU - Tanriover, B.

PY - 2008/8

Y1 - 2008/8

N2 - Immune globulin intravenous (human) (IGIV) is effective in the treatment of various autoimmune and inflammatory disorders. Recently, high-dose IGIV 2 g/kg has been utilized in the treatment of antibody-mediated rejection in solid organ transplantation. We report a renal transplant recipient who developed aseptic meningitis and diplopia from abducens nerve (cranial nerve VI) palsy following IGIV administration for antibody-mediated rejection. Potential mechanisms of the IGIV-related aseptic meningitis are elaborated. Clinicians should be aware of aseptic meningitis and cranial nerve palsy as an adverse reaction to IGIV exposure and monitor for its signs and symptoms.

AB - Immune globulin intravenous (human) (IGIV) is effective in the treatment of various autoimmune and inflammatory disorders. Recently, high-dose IGIV 2 g/kg has been utilized in the treatment of antibody-mediated rejection in solid organ transplantation. We report a renal transplant recipient who developed aseptic meningitis and diplopia from abducens nerve (cranial nerve VI) palsy following IGIV administration for antibody-mediated rejection. Potential mechanisms of the IGIV-related aseptic meningitis are elaborated. Clinicians should be aware of aseptic meningitis and cranial nerve palsy as an adverse reaction to IGIV exposure and monitor for its signs and symptoms.

KW - Abducens nerve palsy

KW - Adverse effect

KW - Aseptic meningitis

KW - Diplopia

KW - IGIV

KW - Immune globulin intravenous

KW - Renal transplant

UR - http://www.scopus.com/inward/record.url?scp=47849088459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47849088459&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3062.2007.00294.x

DO - 10.1111/j.1399-3062.2007.00294.x

M3 - Article

C2 - 18086279

AN - SCOPUS:47849088459

VL - 10

SP - 294

EP - 297

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 4

ER -